hydroxyindoleacetic acid has been researched along with g(m1) ganglioside in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramoto, S; Okamoto, Y; Shigemori, M; Watanabe, T | 1 |
| Hadjiconstantinou, M; Neff, NH; Yates, AJ | 1 |
| Hadjiconstantinou, M; Neff, NH | 1 |
| Inanaga, K; Jonsson, G; Kojima, H; Nagatsu, I; Nishi, S; Toffano, G; Tsutsumi, T; Yamada, S; Yokoo, H | 1 |
| Beni, M; Consolazione, A; Lombardi, G; Moroni, F | 1 |
| Beni, M; Carla', V; Lombardi, G; Moroni, F; Toffano, G | 1 |
| Ali, SF | 1 |
| Bråne, G; Karlsson, I; Lekman, A; Ramström, I; Svennerholm, L; Wikkelsö, C | 1 |
1 trial(s) available for hydroxyindoleacetic acid and g(m1) ganglioside
| Article | Year |
|---|---|
Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.
Topics: Aged; Alzheimer Disease; Cerebrovascular Circulation; Female; G(M1) Ganglioside; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Middle Aged; Neuropsychological Tests; Somatostatin; Treatment Outcome | 2002 |
7 other study(ies) available for hydroxyindoleacetic acid and g(m1) ganglioside
| Article | Year |
|---|---|
Effect of monosialoganglioside (GM1) on transected monoaminergic pathways.
Topics: Animals; Cerebral Cortex; G(M1) Ganglioside; Hydroxyindoleacetic Acid; Male; Mice; Nerve Crush; Nerve Regeneration; Norepinephrine; Serotonin | 1990 |
Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Animals, Newborn; Brain; Choline; Corpus Striatum; Dopamine; Frontal Lobe; G(M1) Ganglioside; Hippocampus; Hydroxyindoleacetic Acid; Hypoxia; Neurons; Neurotransmitter Agents; Organ Size; Rats; Serotonin | 1990 |
Treatment with GM1 ganglioside increases rat spinal cord indole content.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dopamine; G(M1) Ganglioside; Hydroxyindoleacetic Acid; Indoles; Male; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord | 1986 |
The effects of exogenous GM1 ganglioside on neurotoxin induced damage of cerebral serotonin nerve terminals in adult rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; G(M1) Ganglioside; Hydroxyindoleacetic Acid; Male; Neurotoxins; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1988 |
Lesioning and recovery of the serotoninergic hippocampal afferents: differential effects of GM1 ganglioside.
Topics: Afferent Pathways; Animals; Brain; G(M1) Ganglioside; Hippocampus; Hydroxyindoleacetic Acid; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1988 |
Differential actions of neurotrophic factors on lesion-induced damage of the serotonergic neurons projecting to the hippocampus.
Topics: Animals; Brain; Choline O-Acetyltransferase; Functional Laterality; G(M1) Ganglioside; Hippocampus; Hydroxyindoleacetic Acid; Male; Mesencephalon; Nerve Growth Factors; Neurons; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Tryptophan | 1988 |
Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Reactive Oxygen Species; Serotonin; Vitamin E | 1995 |